ResearcherUniversité de SherbrookeActive in the last 2 years

Sarah Mansouri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0034-8088; OpenAlex author ID A5003363550. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatment studies. Co-author DOI 10.1016/j.xpro.2026.104897 ↗
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1071751 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lee‐Hwa Tai · 2 shared papers, 2023–2026 · strength 0.51
- Paper Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatme… DOI 10.1016/j.xpro.2026.104897 ↗
- Paper Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic … DOI 10.3389/fonc.2023.1071751 ↗
Jacob L. Léger · 1 shared paper, 2026 · strength 0.32
- Paper Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatme… DOI 10.1016/j.xpro.2026.104897 ↗
Jeanette E. Boudreau · 1 shared paper, 2023 · strength 0.19
- Paper Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic … DOI 10.3389/fonc.2023.1071751 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.